Dugo, M.; Devecchi, A.; De Cecco, L.; Cecchin, E.; Mezzanzanica, D.; Sensi, M.; Bagnoli, M.
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study. Genes 2019, 10, 678.
https://doi.org/10.3390/genes10090678
AMA Style
Dugo M, Devecchi A, De Cecco L, Cecchin E, Mezzanzanica D, Sensi M, Bagnoli M.
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study. Genes. 2019; 10(9):678.
https://doi.org/10.3390/genes10090678
Chicago/Turabian Style
Dugo, Matteo, Andrea Devecchi, Loris De Cecco, Erika Cecchin, Delia Mezzanzanica, Marialuisa Sensi, and Marina Bagnoli.
2019. "Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study" Genes 10, no. 9: 678.
https://doi.org/10.3390/genes10090678
APA Style
Dugo, M., Devecchi, A., De Cecco, L., Cecchin, E., Mezzanzanica, D., Sensi, M., & Bagnoli, M.
(2019). Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study. Genes, 10(9), 678.
https://doi.org/10.3390/genes10090678